- Home
- ACRV vs NDLS Comparison
ACRV vs NDLS Comparison
Compare ACRV & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- NDLS
- Stock Information
- Founded
- ACRV 2018
- NDLS 1995
- Country
- ACRV United States
- NDLS United States
- Employees
- ACRV N/A
- NDLS N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- NDLS Restaurants
- Sector
- ACRV Health Care
- NDLS Consumer Discretionary
- Exchange
- ACRV Nasdaq
- NDLS Nasdaq
- Market Cap
- ACRV 40.4M
- NDLS 32.9M
- IPO Year
- ACRV 2022
- NDLS 2013
- Fundamental
- Price
- ACRV $1.34
- NDLS $0.90
- Analyst Decision
- ACRV Buy
- NDLS Strong Buy
- Analyst Count
- ACRV 7
- NDLS 2
- Target Price
- ACRV $17.60
- NDLS $3.00
- AVG Volume (30 Days)
- ACRV 379.9K
- NDLS 224.0K
- Earning Date
- ACRV 08-12-2025
- NDLS 08-06-2025
- Dividend Yield
- ACRV N/A
- NDLS N/A
- EPS Growth
- ACRV N/A
- NDLS N/A
- EPS
- ACRV N/A
- NDLS N/A
- Revenue
- ACRV N/A
- NDLS $495,670,000.00
- Revenue This Year
- ACRV N/A
- NDLS $5.37
- Revenue Next Year
- ACRV N/A
- NDLS $0.68
- P/E Ratio
- ACRV N/A
- NDLS N/A
- Revenue Growth
- ACRV N/A
- NDLS N/A
- 52 Week Low
- ACRV $1.05
- NDLS $0.55
- 52 Week High
- ACRV $10.16
- NDLS $1.83
- Technical
- Relative Strength Index (RSI)
- ACRV 55.88
- NDLS 61.53
- Support Level
- ACRV $1.15
- NDLS $0.66
- Resistance Level
- ACRV $1.38
- NDLS $0.82
- Average True Range (ATR)
- ACRV 0.09
- NDLS 0.08
- MACD
- ACRV 0.02
- NDLS 0.02
- Stochastic Oscillator
- ACRV 83.33
- NDLS 93.68
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.